NOXXON Pharma AG

HEALTH & SOCIAL OTHER SERVICES BERLIN STARTUP CHARLOTTENBURG

NOXXON Pharma is a biotechnology company whose core focus is on cancer treatment. NOXXON is using its proprietary class of drugs called Spiegelmers* to target the tumor microenvironment, a new frontier in cancer treatment. NOXXON's goal is to significantly enhance the effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. NOXXON's Spiegelmer platform has generated a broad proprietary pipeline of clinical-stage assets including its lead cancer candidate NOX-A12 and additional candidates outside oncology: Pipeline

NOXXON Pharma is a biotechnology company whose core focus is on cancer treatment. NOXXON is using its proprietary class of drugs called Spiegelmers* to target the tumor microenvironment, a new frontier in cancer treatment. NOXXON's goal is to significantly enhance the effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy.

NOXXON's Spiegelmer platform has generated a broad proprietary pipeline of clinical-stage assets including its lead cancer candidate NOX-A12 and additional candidates outside oncology: Pipeline

Statistics

  1 Like  
Max-Dohrn-Str. 8-10
10589 Berlin, Deutschland

P: +49 30 726247 0
E: sgruender@noxxon.com
W: www.noxxon.com/

User Ratings

0
1
0
0
0

Businesses nearby

BBDC (2.66 km)

JG-Bits (2.02 km)

Lillika Eden (2.24 km)

crowdee (2.87 km)